Overview
Advita Ortho designs and sells orthopedic implants and integrated surgical technologies, including established lines like Equinoxe Shoulder, Vantage Ankle, Alteon Hip, and Truliant Knee. Its products pair implants with tools such as Newton balancing technology and GPS navigation to guide surgeries, while using data, AI, and machine learning to build a surgical ecosystem that supports in-OR decision-making. The company differentiates itself by combining hardware with data-driven software to improve efficiency and outcomes, backed by experienced leadership and significant financial support from its investors. Its goal is to deliver high-quality implants and connected surgical technology that enhance patient outcomes and streamline operating-room workflow globally.
Work here?Claim your company
Simplify's take
What believers are saying
- November 10, 2026 first Vantage ankle surgeries in Japan expand distribution beyond the United States.
- July 27, 2026 Bauer IP acquisition strengthens Advita’s shoulder portfolio against Stryker and Zimmer Biomet.
- September 2026 Axis launch and 7,000 Newton cases deepen surgeon engagement and clinical evidence.
What critics are saying
- FDA issued a December 19, 2025 warning letter after Sarasota inspection failures and stale deviations.
- February 3, 2026 recall of Equinoxe Core Instrument Kit shows basic quality-control breakdowns.
- Exactech MDL 3044 and the settlement trust keep defects litigation alive through 2026, threatening cash and reputation.
What makes Advita Ortho unique
- Advita Ortho controls Exactech’s Equinoxe, Vantage, Alteon, Truliant lines after the 2025 restructuring.
- Aurelio Sahagun joined in November 2025, bringing Medtronic, MicroPort Orthopedics, and Straumann experience.
- June 2026 CAOS studies tied AI twins, GPS navigation, and Newton balancing into one workflow.
Help us improve and share your feedback! Did you find this helpful?